216 related articles for article (PubMed ID: 3257162)
1. Enhancement of in vivo and in vitro murine immune responses by the cyclophosphamide metabolite acrolein.
Kawabata TT; White KL
Cancer Res; 1988 Jan; 48(1):41-5. PubMed ID: 3257162
[TBL] [Abstract][Full Text] [Related]
2. Investigation on cyclophosphamide treatment during the preimplantation period. II. In vitro studies on the effects of cyclophosphamide and its metabolites 4-OH-cyclophosphamide, phosphoramide mustard, and acrolein on blastulation of four-cell and eight-cell mouse embryos and on their subsequent development during implantation.
Spielmann H; Jacob-Müller U
Teratology; 1981 Feb; 23(1):7-13. PubMed ID: 7245091
[TBL] [Abstract][Full Text] [Related]
3. Effect of acrolein on phosphoramide mustard-induced sister chromatid exchanges in cultured human lymphocytes.
Wilmer JL; Erexson GL; Kligerman AD
Cancer Res; 1990 Aug; 50(15):4635-8. PubMed ID: 2369740
[TBL] [Abstract][Full Text] [Related]
4. Comparative effects of cyclophosphamide, isophosphamide, 4-methylcyclophosphamide, and phosphoramide mustard on murine hematopoietic and immunocompetent cells.
Sensenbrenner LL; Marini JJ; Colvin M
J Natl Cancer Inst; 1979 Apr; 62(4):975-81. PubMed ID: 285298
[TBL] [Abstract][Full Text] [Related]
5. Effects of phosphoramide mustard and acrolein, cytotoxic metabolites of cyclophosphamide, on mouse limb development in vitro.
Hales BF
Teratology; 1989 Jul; 40(1):11-20. PubMed ID: 2763206
[TBL] [Abstract][Full Text] [Related]
6. Cyclophosphamide modulates rat hepatic cytochrome P450 2C11 and steroid 5 alpha-reductase activity and messenger RNA levels through the combined action of acrolein and phosphoramide mustard.
Chang TK; Waxman DJ
Cancer Res; 1993 Jun; 53(11):2490-7. PubMed ID: 8495410
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxicity, DNA cross-linking, and single strand breaks induced by activated cyclophosphamide and acrolein in human leukemia cells.
Crook TR; Souhami RL; McLean AE
Cancer Res; 1986 Oct; 46(10):5029-34. PubMed ID: 3463409
[TBL] [Abstract][Full Text] [Related]
8. Regulation of delayed-type hypersensitivity. III. Effect of cyclophosphamide on the suppressor cells for delayed-type hypersensitivity to sheep erythrocytes in mice.
Gill HK; Liew FY
Eur J Immunol; 1978 Mar; 8(3):172-6. PubMed ID: 306925
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the mutagenicity and teratogenicity of cyclophosphamide and its active metabolites, 4-hydroxycyclophosphamide, phosphoramide mustard, and acrolein.
Hales BF
Cancer Res; 1982 Aug; 42(8):3016-21. PubMed ID: 7046914
[No Abstract] [Full Text] [Related]
10. Direct in vitro evidence for different susceptibilities to 4-hydroperoxycyclophosphamide of antigen-primed T cells regulating humoral and cell-mediated immune responses to sheep erythrocytes: a possible explanation for the inverse action of cyclophosphamide on humoral and cell-mediated immune responses.
Diamantstein T; Klos M; Hahn H; Kaufmann SH
J Immunol; 1981 May; 126(5):1717-9. PubMed ID: 6452475
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of T suppressor cell function by local administration of an active cyclophosphamide derivative at the sensitization site.
Limpens J; Scheper RJ
Clin Exp Immunol; 1991 Jun; 84(3):383-8. PubMed ID: 1828396
[TBL] [Abstract][Full Text] [Related]
12. Effect of fractional cyclophosphamide dosage on sheep red blood cell-delayed-type hypersensitivity response in mice.
Rondinone SN; Giovanniello OA; Barrios HA; Nota NR
J Immunol; 1983 Apr; 130(4):1600-3. PubMed ID: 6220061
[TBL] [Abstract][Full Text] [Related]
13. An immunotoxicological evaluation of gamma-chlordane.
Johnson KW; Holsapple MP; Munson AE
Fundam Appl Toxicol; 1986 Feb; 6(2):317-26. PubMed ID: 3486141
[TBL] [Abstract][Full Text] [Related]
14. Effects of warfarin administration on the immune response of mice.
Berkarda B; Marrack P; Kappler JW; Bakemeier RF
Arzneimittelforschung; 1978; 28(8):1407-10. PubMed ID: 380582
[TBL] [Abstract][Full Text] [Related]
15. Role of metabolites of cyclophosphamide in cardiotoxicity.
Kurauchi K; Nishikawa T; Miyahara E; Okamoto Y; Kawano Y
BMC Res Notes; 2017 Aug; 10(1):406. PubMed ID: 28807058
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of in vitro immunosuppression by hepatocyte-generated cyclophosphamide metabolites and 4-hydroperoxycyclophosphamide.
Kawabata TT; Chapman MY; Kim DH; Stevens WD; Holsapple MP
Biochem Pharmacol; 1990 Sep; 40(5):927-35. PubMed ID: 2117927
[TBL] [Abstract][Full Text] [Related]
17. Cyclophosphamide-induced immunologically mediated regression of a cyclophosphamide-resistant murine tumor: a consequence of eliminating precursor L3T4+ suppressor T-cells.
Awwad M; North RJ
Cancer Res; 1989 Apr; 49(7):1649-54. PubMed ID: 2522344
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of sheep erythrocyte (SRBC)-induced pleurisy in non-sensitized mice by cyclophosphamide: demonstration of natural cell-mediated immune reactivity to SRBC.
Yamamoto S; Higuchi Y; Teshima H
Immunology; 1982 Sep; 47(1):31-40. PubMed ID: 7118162
[TBL] [Abstract][Full Text] [Related]
19. Relative susceptibilities of T cell subsets involved in delayed-type hypersensitivity to sheep red blood cells to the in vitro action of 4-hydroperoxycyclophosphamide.
Kaufmann SH; Hahn H; Diamantstein T
J Immunol; 1980 Sep; 125(3):1104-8. PubMed ID: 6967888
[TBL] [Abstract][Full Text] [Related]
20. Role of acrolein in cyclophosphamide teratogenicity in rat embryos in vitro.
Mirkes PE; Greenaway JC; Rogers JG; Brundrett RB
Toxicol Appl Pharmacol; 1984 Feb; 72(2):281-91. PubMed ID: 6546458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
